What Do We Measure in Oncology PET? / 대한핵의학회잡지
Korean Journal of Nuclear Medicine
;
: 212-216, 2017.
Artigo
em Inglês
| WPRIM
| ID: wpr-786939
ABSTRACT
Positron emission tomography (PET) has come to the practice of oncology. It is known that 18F-fluorodeoxyglucose (FDG) PET is more sensitive for the assessment of treatment response than conventional imaging. In addition, PET has an advantage in the use of quantitative analysis of the study. Nowadays, various PET parameters are adopted in clinical settings. In addition, a wide range of factors has been known to be associated with FDG uptake. Therefore, there has been a need for standardization and harmonization of protocols and PET parameters. We will introduce PET parameters and discuss major issues in this review.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Processamento de Imagem Assistida por Computador
/
Compostos Radiofarmacêuticos
/
Tomografia por Emissão de Pósitrons
/
Oncologia
Tipo de estudo:
Guia de Prática Clínica
Idioma:
Inglês
Revista:
Korean Journal of Nuclear Medicine
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS